$114,071
＋10%
Chief Executive Officer
2024
$115k
40 hrs/wk
Chief Executive Officer at Congenital Hyperinsulinism International
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Julie Raskin has been listed as an employee of Congenital Hyperinsulinism International in Form 990 filings since at least fiscal year 2016. Total compensation for Julie Raskin has increased by 80.4% from 2016 to 2024.